About this trial

This project will compare the uptake of cervical cancer screening through ED HPV sampling among patients presenting to the ED.

Eligibility criteria

Qualifiers

Cisgender women and transgender/non-binary individuals with a cervix,

Age 30 - 65 years, and demonstrating decisional capacity to consent to participate with no known

Disqualifiers

Past hysterectomy with cervical removal

Known infection with HIV (as screening recommendations for people with HIV differ from the general population)

Inability to consent (e.g., lacking decisional capacity, intoxicated, or in distress)

Current pregnancy or in the three months after giving birth

Trial design

Treatments tested in this trial

  • Cervical Cancer Screening

Treatment groups

200 Participants
are divided into 1 treatment group

Locations

1
University of Rochester Strong Memorial Hospital14642, RochesterNew York, United States

Sponsors and collaborators

University of Rochester

Lead sponsor